We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.50 | 0.28% | 1,640.50 | 1,640.00 | 1,640.50 | 1,656.00 | 1,635.00 | 1,642.00 | 5,918,777 | 16:29:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.71 | 67.54B |
TIDMGSK
RNS Number : 6936P
GlaxoSmithKline PLC
11 October 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Ms E Walmsley ==== ====================================== ================================================= b) Position/status Chief Executive Officer ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019, on shares held through the Company's Share Reward Plan. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.1842 18 ===================================================================== =================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr R Connor ==== ====================================== ================================================= b) Position/status President, Global Vaccines ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019, on shares held through the Company's Share Reward Plan. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.1842 61 ===================================================================== =================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr N Hirons ==== ====================================== ================================================= b) Position/status SVP, Global Ethics & Compliance ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019, on shares held through the Company's Share Reward Plan. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.1842 12 ===================================================================== =================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== =================================================
1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Ms S Jackson ==== ====================================== ================================================= b) Position/status SVP, Global Communications and CEO Office ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019, on shares held through the Company's Share Reward Plan. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.1842 56 ===================================================================== =================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr D Jackson ==== ====================================== ====================================================== b) Position/status PCA of Mrs S Jackson (SVP, Global Communications and CEO Office) ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GlaxoSmithKline plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ====================================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019, on shares held through the Company's Share Reward Plan. ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP17.1842 19 ======================================================================= ====================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ==================================================================== ============================= e) Date of the transaction 2019-10-10 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr L Miels ==== ====================================== ================================================= b) Position/status President, Global Pharmaceuticals ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019, on shares held through the Company's Share Reward Plan. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.1842 3 ===================================================================== =================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction
==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr D Redfern ==== ====================================== ================================================= b) Position/status Chief Strategy Officer ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019, on shares held through the Company's Share Reward Plan. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.1842 69 ===================================================================== =================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr R Simard ==== ====================================== ================================================= b) Position/status President, Pharmaceuticals Supply Chain ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019, on shares held through the Company's Share Reward Plan. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.1842 18 ===================================================================== =================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr P C Thomson ==== ====================================== ================================================= b) Position/status President, Global Affairs ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019, on shares held through the Company's Share Reward Plan. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.1842 39 ===================================================================== =================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them
('PCA') ==== ========================================================================================= a) Name Ms V A Whyte ==== ====================================== ================================================= b) Position/status Company Secretary ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019, on shares held through the Company's Share Reward Plan. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.1842 50 ===================================================================== =================== d) Aggregated information n/a (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== =================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHQFLFFKBFXFBL
(END) Dow Jones Newswires
October 11, 2019 12:34 ET (16:34 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions